How better drugs could change kala-azar control; lessons from a cost-effectiveness analysis

M Boelaert, D Le Ray, P Van der Stuyft

Research output: Contribution to journalA1: Web of Science-article

Original languageEnglish
JournalTropical Medicine and International Health
Volume7
Pages (from-to)955-959
ISSN1360-2276
DOIs
Publication statusPublished - 2002

Keywords

  • B780-tropical-medicine
  • Protozoal diseases
  • Leishmaniasis
  • Visceral
  • Kala azar
  • Drug therapy
  • Efficacy
  • Toxicity
  • Counterfeit drugs
  • Substandard drugs
  • Quality assurance
  • Compliance
  • Drug resistance
  • Drug development
  • Cost-effectiveness

Cite this